HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The epidemiology and progression time from transient to permanent psychiatric disorders of substance-induced psychosis in Taiwan.

AbstractINTRODUCTION:
Substance-induced psychosis (SIP), including alcohol-induced psychotic disorder (AIPD) and substance-induced psychotic disorder (SIPD), is gradually increasing in importance in clinical practice. However, few studies have investigated the epidemiology and progression time from transient to permanent psychiatric disorders for AIPD and SIPD patients.
METHODS:
We utilized the National Health Insurance Research Database (NHIRD) to investigate the incidence and prevalence of AIPD and SIPD in Taiwan and determined the timing of AIPD or SIPD followed by the development of persistent psychotic conditions.
RESULTS:
The average incidence and prevalence were 1.97 and 2.94 per 100,000 person-years for AIPD, 3.09 and 5.67 per 100,000 person-years for SIPD in Taiwan. Moreover, 10.9% to 24.3% of subjects with either AIPD or SIPD had a change in diagnosis to either schizophrenia or affective disorder, and ~50% of patients had a psychotic or affective transformation in their first year after AIPD and SIPD diagnoses. The mean progression time of psychotic or affective transformation was 1.9 to 2.7 years.
CONCLUSIONS:
SIP is a predictive factor for persistent psychotic and affective transformation, and a three-year follow-up may be an optimal clinical practice to prevent psychotic or affective transformation in 60% of patients.
AuthorsWei-Ling Chen, Chia-Hung Hsieh, Hao-Teng Chang, Chia-Chun Hung, Chin-Hong Chan
JournalAddictive behaviors (Addict Behav) Vol. 47 Pg. 1-4 (Aug 2015) ISSN: 1873-6327 [Electronic] England
PMID25841087 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015. Published by Elsevier Ltd.
Topics
  • Adult
  • Disease Progression
  • Female
  • Humans
  • Incidence
  • Male
  • Prevalence
  • Psychoses, Substance-Induced (epidemiology)
  • Sex Distribution
  • Taiwan (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: